Metraipolis › archive › dc_13b58cd466be
Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity — Europe PMC PMID:42957176
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42957176
- DOI
- 10.5041/rmmj.10585
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T07:54:42.710Z
- SHA-256 of the archived text
7aacd2b984e0fb56106b3a81c6449dded784558ba01e6e1412f4c0bd683063da- Stable URL of this page
https://metraipolis.com/documento/dc_13b58cd466be
How to cite
Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity — Europe PMC PMID:42957176 — Europe PMC (en), https://europepmc.org/article/MED/42957176 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_13b58cd466be (Metraipolis archive dc_13b58cd466be, sha256 7aacd2b984e0fb56106b3a81c6449dded784558ba01e6e1412f4c0bd683063da)
BibTeX
@misc{dc13b58cd466be,
title = {Neuropsychiatric Safety of GLP-1 Receptor Agonists and Tirzepatide in Adults with Type 2 Diabetes Mellitus or Obesity — Europe PMC PMID:42957176},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42957176},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_13b58cd466be; sha256 7aacd2b984e0fb56106b3a81c6449dded784558ba01e6e1412f4c0bd683063da},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42957176. Agents can read the archived copy with the MCP tool read_document.